Nataliya Razumilava
- Surgery top 5%
- Molecular Biology
- Hepatology top 2%
- Cancer Research top 5%
- Oncology top 10%
- Co-authors
- Gregory J. GoresKeith D. LindorXin ChenChristian D. FingasRory L. SmootFrank DombrowskiSilvia RibbackMatthias Evert
- Topics
- Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers)Pediatric Hepatobiliary Diseases and Treatments (8 papers)Hedgehog Signaling Pathway Studies (5 papers)
- Cited by
- HepatologyCancer ResearchSurgery
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Nataliya Razumilava
28 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 83
- Surgery 1.0k
- Molecular Biology 507
- Hepatology 469
- Cancer Research 413
- Oncology 403
Countries citing papers authored by Nataliya Razumilava
This map shows the geographic impact of Nataliya Razumilava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nataliya Razumilava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nataliya Razumilava more than expected).
Fields of papers citing papers by Nataliya Razumilava
This network shows the impact of papers produced by Nataliya Razumilava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nataliya Razumilava. The network helps show where Nataliya Razumilava may publish in the future.
Co-authorship network of co-authors of Nataliya Razumilava
This figure shows the co-authorship network connecting the top 25 collaborators of Nataliya Razumilava. A scholar is included among the top collaborators of Nataliya Razumilava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nataliya Razumilava. Nataliya Razumilava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 49 | |
| 6 | 9 | |
| 7 | 9 | |
| 8 | 67 | |
| 9 | 26 | |
| 10 | 28 | |
| 11 | 22 | |
| 12 | 35 | |
| 13 | 66 | |
| 14 | 0 | |
| 15 | 49 | |
| 16 | 351 | |
| 17 | 220 | |
| 18 | 163 | |
| 19 | 201 | |
| 20 | Sorafenib for HCC: a pragmatic perspective. | 4 |
About Nataliya Razumilava
Nataliya Razumilava is a scholar working on Hepatology, Surgery and Cancer Research, having authored 29 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers), Pediatric Hepatobiliary Diseases and Treatments (8 papers) and Hedgehog Signaling Pathway Studies (5 papers). The work is most often cited by research in Hepatology (469 citations), Cancer Research (413 citations) and Surgery (1.0k citations). Nataliya Razumilava has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Gregory J. Gores, Keith D. Lindor, Xin Chen, Christian D. Fingas, Rory L. Smoot, Frank Dombrowski, Silvia Ribback, Matthias Evert, Holger Willenbring and Biao Fan. Their work appears in journals such as Journal of Clinical Investigation, Hepatology and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.